ArticleESMO real world data and digital oncology2026

Optimisation and validation of line-of-therapy advancement algorithms in advanced/metastatic non-small-cell lung cancer: an I-O Optimise study.

S Lay-Flurrie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.